Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Athersys, Inc. (NASDAQ: ATHX).

Full DD Report for ATHX

You must become a subscriber to view this report.


Recent News from (NASDAQ: ATHX)

Athersys' (ATHX) CEO Gil Van Bokkelen on Q1 2018 Results - Earnings Call Transcript
Athersys (ATHX) Q1 2018 Earnings Conference Call May 10, 2018 04:30 PM ET Executives Laura Campbell - SVP, Finance BJ Lehmann - President and COO Gil Van Bokkelen - Chairman and CEO Analysts Chad Messer - Needham & Company Jason McCarthy - Maxim Presentation Op...
Source: SeekingAlpha
Date: May, 10 2018 19:13
Athersys Reports First Quarter 2018 Results
CLEVELAND, May 10, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today its financial results for the three months ended March 31, 2018. Highlights of the first quarter of 2018 and recent events include: Completed a $21.1 million equity investment and announced plans ...
Source: GlobeNewswire
Date: May, 10 2018 16:03
Athersys and Healios Extend by One Month the Period to Complete Collaboration Expansion Agreements
CLEVELAND and TOKYO, May 01, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) and HEALIOS K.K. (“Healios”) (TSE Mothers Code:4593) have agreed to extend the period from April 30, 2018 to May 31, 2018 to complete their planned collaboration expansion agreements, as defined...
Source: GlobeNewswire
Date: May, 01 2018 06:00
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Delaware Law by the Board of Athersys, Inc. -- ATHX
Levi & Korsinsky announces it has commenced an investigation of Athersys, Inc. (NASDAQCM: ATHX) concerning possible breaches of Delaware law by the board of directors of the company. To obtain additional information, go to : http://www.zlkdocs.com/ATHX-Info-Request-Form-6652 ...
Source: Business Wire
Date: April, 27 2018 09:45
Recent Analysis Shows First Cash, ADTRAN, OMNOVA Solutions, Athersys, Oppenheimer, and Conn's Market Influences - Renewed Outlook, Key Drivers of Growth
NEW YORK, April 25, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of First Cash, Inc. (NYSE:FCFS), ADTRAN, Inc. (NASDAQ:ADTN), OMNOVA Solutio...
Source: GlobeNewswire
Date: April, 25 2018 07:50
UTHealth in Houston and Athersys Announce Funding for Clinical Trial using MultiStem® to Treat Trauma Patients
CLEVELAND, April 23, 2018 (GLOBE NEWSWIRE) -- The University of Texas Health Science Center at Houston (UTHealth) and Athersys, Inc. (NASDAQ:ATHX) today announced plans to conduct a Phase 2 clinical trial evaluating Athersys’ MultiStem ® cell therapy for early treatment and pre...
Source: GlobeNewswire
Date: April, 23 2018 06:00
Catalyst Pipeline Portfolio Updates - Strong Start To For The Portfolio
Investment Thesis and Portfolio Focus: Investment across the biotech space (large and small) often sees a significant amount of risk associated with pipeline success and timelines. We've established a small group of biotechs which have significant catalysts in 2018 which include partnership ...
Source: SeekingAlpha
Date: April, 18 2018 15:41
Athersys/Healios Warrant Structure Bullish For Athersys Shares
It's been about a month since Athersys ( ATHX ) announced the signing of a letter of intent (LOI) related to expanding its relationship with Healios K.K ., a leading regenerative medicine company in Japan. The agreement will raise a minimum of $56,000,000 for the company over the next coupl...
Source: SeekingAlpha
Date: April, 16 2018 14:08
Athersys (ATHX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow
The following slide deck was published by Athersys, Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: March, 29 2018 13:03
Wired News - Reata Pharma Reports Positive Top-line Data from its Phase-2 LARIAT Trial
Stock Monitor: Athersys Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 26, 2018 / Active-Investors.com has just released a free research report on Reata Pharmaceuticals, Inc. (NASDAQ: RETA ). If you want access to this report all you need to do is sign up now by clicking the...
Source: ACCESSWIRE IA
Date: March, 26 2018 07:10

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-171.971.94991.991.91199,256
2018-08-161.971.98052.021.92252,939
2018-08-152.051.94992.051.93431,605
2018-08-142.042.052.072.01174,588
2018-08-132.062.042.08531.99235,938

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1745,271114,24539.6262Short
2018-08-1637,531129,87428.8980Cover
2018-08-1561,426148,29741.4209Short
2018-08-1415,83084,48518.7371Cover
2018-08-1335,337109,76132.1945Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ATHX.


About Athersys, Inc. (NASDAQ: ATHX)

Logo for Athersys, Inc. (NASDAQ: ATHX)

Not available

 

Contact Information

 

 

Current Management

  • Gil Van Bokkelen / CEO
  • Gil Van Bokkelen /

Current Share Structure

  • Market Cap: $278,085,032 - 05/14/2018
  • Issue and Outstanding: 125,830,331 - 03/07/2018

 


Recent Filings from (NASDAQ: ATHX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 26 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 26 2018
Filing by person(s) reporting owned shares of common stock in a public company >5%
Filing Type: SC 13DFiling Source: edgar
Filing Date: March, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 16 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 13 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: February, 14 2018

 

 


Daily Technical Chart for (NASDAQ: ATHX)

Daily Technical Chart for (NASDAQ: ATHX)


Stay tuned for daily updates and more on (NASDAQ: ATHX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ATHX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ATHX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of ATHX and does not buy, sell, or trade any shares of ATHX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/